Teva To Divest Women's Health, Some Oncology As CEO Search Proceeds

 
• By Jessica Merrill

The company is pursuing the sale of global women's health and its oncology and pain businesses in Europe, Interim CEO Yitzhak Peterburg said during the firm's first quarter earnings call.

Samples of medicines, tablets, capsules, vitamins, and placebo

More from Earnings

More from Business